AYALA PHARMACEUTICALS INC (AYLA) Stock Balance Sheet
NASDAQ:AYLA - Nasdaq - US05465V1089 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.20M | 36.98M | 42.03M | 16.73M | 26.10M | |||
| Receivables | 129.00K | 0.00 | 680.00K | 470.00K | 0.00 | |||
| Other Current Assets | 1.71M | 2.76M | 1.53M | 500.00K | 760.00K | |||
| Total Current Assets | 13.03M | 39.74M | 44.24M | 17.69M | 26.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | 999.00K | 1.12M | 1.28M | 1.42M | 240.00K | |||
| Other Non-Current Assets | 229.00K | 267.00K | 310.00K | 940.00K | 30.00K | |||
| Total Non-Current Assets | 1.23M | 1.39M | 1.59M | 2.36M | 280.00K | |||
| TOTAL ASSETS | 14.26M | 41.13M | 45.83M | 20.05M | 27.13M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.38M | 2.11M | 1.61M | 1.94M | 1.53M | |||
| Accounts Payable | 2.33M | 3.21M | 4.48M | 2.92M | 950.00K | |||
| Other Current Liabilities | N/A | 1.15M | 780.00K | 440.00K | 290.00K | |||
| Total Current Liabilities | 5.71M | 6.47M | 6.88M | 5.30M | 2.77M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 396.00K | 497.00K | 550.00K | 300.00K | 0.00 | |||
| Total Non-Current Liabilities | 396.00K | 497.00K | 550.00K | 300.00K | 0.00 | |||
| TOTAL LIABILITIES | 6.10M | 6.97M | 7.43M | 5.60M | 2.77M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -139.57M | -111.14M | -70.89M | -40.74M | -22.95M | |||
| Additional Paid In Capital | 147.59M | 145.16M | 109.16M | 1.72M | 990.00K | |||
| Common Shares | 139.00K | 139.00K | 130.00K | 53.47M | 46.31M | |||
| Shares Outstanding | 14.30M | 13.96M | 12.73M | 10.13M | 10.13M | |||
| Tangible Book Value per Share | 0.57 | 2.45 | 3.02 | -3.84 | -2.16 | |||
| Total Shareholders' Equity | 8.16M | 34.16M | 38.40M | 14.45M | 24.35M | |||
| TOTAL LIABILITIES AND EQUITY | 14.26M | 41.13M | 45.83M | 20.05M | 27.13M | |||
| Statistics | ||||||||
| Current Ratio | 2.28 | 6.14 | 6.43 | 3.34 | 9.69 | |||
| Return On Assets (ROA) | -269.80% | -97.88% | -65.79% | -88.73% | -32.69% | |||
| Return On Equity (ROE) | -471.55% | -117.85% | -78.52% | -123.11% | -36.43% | |||
All data in USD , ROIC based on taxRate of 0.21